Use this dropdown to select your preferred language.
NTT DATA is a $30 billion trusted global innovator of IT and business services. We help clients transform through business and technology consulting, industry and digital solutions, applications development and management, managed edge-to-cloud infrastructure services, BPO, systems integration and global data centers. We are committed to our clients’ long-term success and combine global reach with local client service in over 80 countries.
The Fondazione Policlinico Universitario A. Gemelli IRCCS is one of Europe’s largest private hospitals, home to the Catholic University’s Faculty of Medicine and a center of excellence in healthcare, teaching, and research. Recognized as an IRCCS for personalized medicine and biotechnology, it combines high-level care, advanced training, and scientific innovation.
Boehringer Ingelheim Middle East & North Africa
Pharmaceutical Company
please use the eps logo as the png logo is cropped and not full
Boston Scientific Corporation was founded in June 1979. Headquartered in Marlborough, Massachusetts, the company operates in 130 countries and regions around the world. Boston Scientific entered China in 1997. Headquartered in Shanghai, Boston Scientific Greater China employs more than 1,500 people and has branch offices in Beijing, Guangzhou, Chengdu, Hong Kong, and Taipei.
百时美施贵宝是一家以“研发并提供创新药物，帮助患者战胜严重疾病”为使命的全球领先的生物制药公司，始终践行“引领科学，改变患者生命”的企业愿景。
在全球，百时美施贵宝在肿瘤学、血液学、免疫学和心血管疾病领域处于领先地位，并拥有业内最丰富、最具前景的产品管线之一。
在中国，百时美施贵宝致力于成为“根植中国、源于中国”的创新领导者。公司于年进入中国，于同年成立的中美上海施贵宝制药有限公司是中国改革开放以后成立的第一家中美合资制药企业。年来，百时美施贵宝在中国已上市了超过款产品及适应症，涉及肿瘤学、血液学、病毒学及心血管等疾病领域。
如今，百时美施贵宝中国正在成为公司全球研发、制造、商业和创新中心之一。为了惠及更多中国患者，我们将丰富并加快引入百时美施贵宝全球创新产品线，使中国的产品管线与全球一致。同时，作为中国的长期合作伙伴，百时美施贵宝始终致力于与中国政府共同努力，促进药物创新环境并提升中国患者对公司创新药物的可及。